Zhou J (2010) CST Curation Set: 10003; Year: 2010; Biosample/Treatment: cell line, no cells/calyculin_A & pervanadate; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])

This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.

Click on the protein name to open the protein page, and on the RSD number to open the site page.

Download

S455-p - ACLY (human) ▲
Modsite: PAPsRtAsFsEsRAD SwissProt Entrez-Gene Orthologous residues ACLY (human): S455‑p, ACLY iso2 (human): S455‑p, ACLY iso3 (human): S65‑p, ACLY (mouse): S455‑p, ACLY iso2 (mouse): S455‑p, ACLY iso3 (mouse): S455‑p, ACLY (rat): S454‑p, ACLY iso2 (rat): S455‑p Characterization Methods used to characterize site in vivo:  mass spectrometry Species studied:  human

S196-p - CRK iso2 (human) ▲
Modsite: KYRPAsAsVSALIGG SwissProt Entrez-Gene Orthologous residues CRK (human): S196‑p, CRK iso2 (human): S196‑p, CRK (mouse): S196‑p, CRK iso3 (mouse): S196‑p, CRK (rat): S196‑p, CRK (chicken): S197‑p Characterization Methods used to characterize site in vivo:  mass spectrometry Species studied:  human

S236-p - DTX2 (human) ▲
Modsite: HPPHrTAsVFGTHQA SwissProt Entrez-Gene Orthologous residues DTX2 (human): S236‑p, DTX2 iso2 (human): S236‑p, DTX2 (mouse): T235‑p, DTX2 (rat): T235‑p Characterization Methods used to characterize site in vivo:  mass spectrometry Species studied:  human

S2152-p - FLNA (human) ▲
Modsite: tRRRRAPsVANVGsH SwissProt Entrez-Gene Orthologous residues FLNA (human): S2152‑p, FLNA iso2 (human): S2144‑p, FLNA (mouse): S2152‑p, FLNA (rat): S2144‑p, FLNA (cow): S2155‑p Characterization Methods used to characterize site in vivo:  mass spectrometry Species studied:  human

S1404-p - FMN1 (human) ▲
Modsite: KKINPTAsLKERLRQ SwissProt Entrez-Gene Orthologous residues FMN1 (human): S1404‑p, FMN1 iso3 (human): ‑, FMN1 iso5 (human): S1181‑p, FMN1 (mouse): S1451‑p, FMN1 iso5 (mouse): S1189‑p, FMN1 (rat): ‑, FMN1 iso3 (rat): ‑ Characterization Methods used to characterize site in vivo:  mass spectrometry Species studied:  human

S463-p - HEFL (human) ▲
Modsite: AGLMLFVsRKWRFRD SwissProt Entrez-Gene Orthologous residues HEFL (human): S463‑p, HEFL iso3 (human): ‑, HEFL (mouse): S461‑p, HEFL (rat): S462‑p Characterization Methods used to characterize site in vivo:  mass spectrometry Species studied:  human

T388-p - LAD1 (human) ▲
Modsite: KKENsETtLTRsAsM SwissProt Entrez-Gene Orthologous residues LAD1 (human): T388‑p, LAD1 (mouse): P399‑p, LAD1 (rat): T390‑p Characterization Methods used to characterize site in vivo:  mass spectrometry Species studied:  human

S824-p - LARP (human) ▲
Modsite: KRKtRHssNPPLEsH SwissProt Entrez-Gene Orthologous residues LARP (human): S824‑p, LARP iso3 (human): S747‑p, LARP (mouse): S801‑p, LARP (rat): S737‑p Characterization Methods used to characterize site in vivo:  mass spectrometry Species studied:  human

S1500-p - LMO7 (human) ▲
Modsite: sVNKEPVsLPGIMRR SwissProt Entrez-Gene Orthologous residues LMO7 (human): S1500‑p, LMO7 iso2 (human): S1500‑p, LMO7 iso3 (human): S1166‑p, LMO7 iso4 (human): S1500‑p, LMO7 (mouse): C1523‑p, LMO7 iso4 (mouse): C983‑p, LMO7 (rat): C1553‑p, LMO7 iso3 (rat): C1219‑p, LMO7 iso4 (rat): ‑ Characterization Methods used to characterize site in vivo:  mass spectrometry Species studied:  human

S1510-p - LMO7 (human) ▲
Modsite: GIMRRGEsLDNLDsP SwissProt Entrez-Gene Orthologous residues LMO7 (human): S1510‑p, LMO7 iso2 (human): S1510‑p, LMO7 iso3 (human): S1176‑p, LMO7 iso4 (human): S1510‑p, LMO7 (mouse): S1533‑p, LMO7 iso4 (mouse): S993‑p, LMO7 (rat): S1563‑p, LMO7 iso3 (rat): S1229‑p, LMO7 iso4 (rat): ‑ Characterization Methods used to characterize site in vivo:  mass spectrometry Species studied:  human

S1516-p - LMO7 (human) ▲
Modsite: EsLDNLDsPRsNsWR SwissProt Entrez-Gene Orthologous residues LMO7 (human): S1516‑p, LMO7 iso2 (human): S1516‑p, LMO7 iso3 (human): S1182‑p, LMO7 iso4 (human): S1516‑p, LMO7 (mouse): S1539‑p, LMO7 iso4 (mouse): S999‑p, LMO7 (rat): S1569‑p, LMO7 iso3 (rat): S1235‑p, LMO7 iso4 (rat): ‑ Characterization Methods used to characterize site in vivo:  mass spectrometry Species studied:  human

S1563-p - LMO7 (human) ▲
Modsite: RAyMRNPsssVPPPs SwissProt Entrez-Gene Orthologous residues LMO7 (human): S1563‑p, LMO7 iso2 (human): S1563‑p, LMO7 iso3 (human): S1229‑p, LMO7 iso4 (human): S1563‑p, LMO7 (mouse): S1586‑p, LMO7 iso4 (mouse): S1046‑p, LMO7 (rat): S1616‑p, LMO7 iso3 (rat): S1282‑p, LMO7 iso4 (rat): ‑ Characterization Methods used to characterize site in vivo:  mass spectrometry Species studied:  human

S1564-p - LMO7 (human) ▲
Modsite: AyMRNPsssVPPPsA SwissProt Entrez-Gene Orthologous residues LMO7 (human): S1564‑p, LMO7 iso2 (human): S1564‑p, LMO7 iso3 (human): S1230‑p, LMO7 iso4 (human): S1564‑p, LMO7 (mouse): S1587‑p, LMO7 iso4 (mouse): S1047‑p, LMO7 (rat): S1617‑p, LMO7 iso3 (rat): S1283‑p, LMO7 iso4 (rat): ‑ Characterization Methods used to characterize site in vivo:  mass spectrometry Species studied:  human

S1573-p - LMO7 (human) ▲
Modsite: VPPPsAGsVKTStTG SwissProt Entrez-Gene Orthologous residues LMO7 (human): S1573‑p, LMO7 iso2 (human): S1573‑p, LMO7 iso3 (human): S1239‑p, LMO7 iso4 (human): S1573‑p, LMO7 (mouse): S1595‑p, LMO7 iso4 (mouse): S1055‑p, LMO7 (rat): S1625‑p, LMO7 iso3 (rat): S1291‑p, LMO7 iso4 (rat): ‑ Characterization Methods used to characterize site in vivo:  mass spectrometry Species studied:  human

S1593-p - LMO7 (human) ▲
Modsite: sPtPrsHsPsAsQsG SwissProt Entrez-Gene Orthologous residues LMO7 (human): S1593‑p, LMO7 iso2 (human): S1593‑p, LMO7 iso3 (human): S1259‑p, LMO7 iso4 (human): S1593‑p, LMO7 (mouse): S1609‑p, LMO7 iso4 (mouse): S1069‑p, LMO7 (rat): S1639‑p, LMO7 iso3 (rat): S1305‑p, LMO7 iso4 (rat): ‑ Characterization Methods used to characterize site in vivo:  mass spectrometry Species studied:  human

Y1469-p - MYO10 (human) ▲
Modsite: GYWNVTVyGRKHCYR SwissProt Entrez-Gene Orthologous residues MYO10 (human): Y1469‑p, MYO10 (mouse): Y1473‑p, MYO10 (rat): Y1471‑p Characterization Methods used to characterize site in vivo:  mass spectrometry Species studied:  human

S1612-p - PLXNA2 (human) ▲
Modsite: yNIPASAsISRTSIS SwissProt Entrez-Gene Orthologous residues PLXNA2 (human): S1612‑p, PLXNA2 (mouse): S1612‑p, PLXNA2 (rat): S1612‑p Characterization Methods used to characterize site in vivo:  mass spectrometry Species studied:  human

S1094-p - RAPGEF6 (human) ▲
Modsite: KKRARRssLLNAKKL SwissProt Entrez-Gene Orthologous residues RAPGEF6 (human): S1094‑p, RAPGEF6 iso2 (human): S1094‑p, RAPGEF6 iso4 (human): S1102‑p, RAPGEF6 (mouse): S1102‑p, RAPGEF6 (rat): S1094‑p, RAPGEF6 (cow): S1106‑p Characterization Methods used to characterize site in vivo:  mass spectrometry Species studied:  human

S359-p - SSF1 (human) ▲
Modsite: KKARVGGsDEEAsGI SwissProt Entrez-Gene Orthologous residues SSF1 (human): S359‑p, SSF1 iso2 (human): S359‑p, SSF1 iso3 (human): S359‑p, SSF1 (mouse): S362‑p, SSF1 (rat): S362‑p Characterization Methods used to characterize site in vivo:  mass spectrometry Species studied:  human

S445-p - TAO1 (human) ▲
Modsite: FAtIRtAsLVTRQMQ SwissProt Entrez-Gene Orthologous residues TAO1 (human): S445‑p, TAO1 iso3 (human): S445‑p, TAO1 (mouse): S445‑p, TAO1 (rat): S445‑p Characterization Methods used to characterize site in vivo:  mass spectrometry Species studied:  human